Michael Frazier, DPM
Podiatrist · Federal Way, WANPI 1881686731
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $19,350 of the $27,285 with a category attached, or 70.9%. Stryker accounts for 98.4% of it on its own, with 11 other manufacturers making up the rest. Reporting peaked in 2019 at $17,829 and has fallen 99.8% since, to $32 in 2025. Among podiatrist clinicians in WA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 248 payments — averaging $110.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$27K
- Comsort, Inc$100
- Imbed Biosciences Inc.$62
- Amgen$45
- Anika Therapeutics, Inc.$43
- Aroa Biosurgery Incorporated$37
- plus $145 from 6 others
What the payments were for
- Consulting fees$19,35071%
- Travel & lodging$1601%
- Food & beverage$7,77528%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker(2 entities) | 233 | $26,853 |
| Comsort, Inc | 1 | $100 |
| Imbed Biosciences Inc. | 2 | $62 |
| Amgen | 3 | $45 |
| Anika Therapeutics, Inc. | 1 | $43 |
| Aroa Biosurgery Incorporated | 1 | $37 |
| Integra Lifesciences Corporation | 2 | $35 |
| Globus Medical | 1 | $32 |
| Johnson & Johnson | 1 | $30 |
| Novo Nordisk | 1 | $18 |
| Treace Medical Concepts, Inc. | 1 | $17 |
| Smith+Nephew | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$27,285 in reported general payments places this provider in the 95th percentile of 134 podiatrist providers in Washington.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ammonium Lactate | 62 | $1,016 |
| Pregabalin | 17 | $952 |
| Gabapentin | 82 | $807 |
| Fluocinonide | 22 | $681 |
| Diclofenac Sodium | 60 | $560 |
| Clotrimazole | 28 | $464 |
| Celecoxib | 27 | $351 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 19 | $244 |
| Methylprednisolone | 27 | $228 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 22 | $118 |
| Furosemide | 25 | $100 |
| Lidocaine-PrilocaineLidocaine/Prilocaine | 14 | $95 |
| Allopurinol | 16 | $56 |
Paid to pharmacies, not to this prescriber.
Other podiatrist in Federal Way
- Thomas LandinoFederal Way$3K
- Byron HutchinsonBurien$903K
- Michael DujelaCentralia$99K
- Huy DangCentralia$63K
- Ryan StoneBurien$15K
- Alvin NganSeattle$13K
- Tony KimWenatchee$11K
- Anthony MollicaBellevue$11K
- Todd ChappellTacoma$9K
- Matthew WilliamsSeattle$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.